Executive Summary
1. General data
1.1 Identity of the
ingredient :
2-Ethylhexyl-4-dimethylaminobenzoate
1.2 CAS n° :
1.3 Use : sunscreen
formulations at a maximum
concentration of 8 %
2. Terms of reference
2.1 Context of the
question
The adaptation to
technical progress of the
Annexes to Council Directive
76/768/EEC of 27 July 1976 on
the approximation of the laws
of the Member States relating
to cosmetic products.
Request for inclusion of
S8 in Annex VII, part 1 - List
of UV filters which Cosmetic
Products may contain - to
Council Directive 76/768/EEC.
2.2 Request to the
SCCNFP
The SCCNFP is requested
to answer the following
questions :
* Is
2-Ethylhexyl-4-dimethylaminobenzoate
safe for use in cosmetic
products?
* Does the SCCNFP
propose any restrictions or
conditions for its use in
cosmetic products?
3. Toxicological
Evaluation &
Characterisation
3.1 Acute toxicity
(dermal, oral, i.v., i.p.) :
Low acute toxicity
3.2 Chronic/sub-chronic
toxicity : No adverse effects
were noted within a reasonable
dose range; a clear NOAEL could
be stated
3.3 Reproductive
toxicity : No evidence of
teratogenic activity, no
embryo-toxicity.
3.4 Photo-toxicity : No
evidence of a photo-toxic
potential
3.5 Percutaneous
absorption : About 2.5 %
3.6 Mucous membrane
Irritation : Slight transient
irritation
3.7 Skin irritation : No
evidence of irritation
3.8 Sensitisation : No,
or only slight reactions
3.9 Mutagenicity : No
evidence of mutagenic potential
3.10 Photo-mutagenicity
: No evidence of
photo-mutagenic potential
4. Opinion : The SCCNFP
is of the opinion that
2-Ethylhexyl-4-dimethylamino-
benzoate can be used safely in
cosmetic sunscreen formulations
at a maximum concentration of 8
%.
The SCCNFP proposes no
further restrictions or
conditions for its use in
cosmetic products.
5. Statement on the
toxicological evaluation
The SCCNFP is the
scientific advisory body to the
European Commission in matters
of consumer protection with
respect to cosmetics and
non-food products intended for
consumers.
The Commission's general
policy regarding research on
animals supports the
development of alternative
methods to replace or to reduce
animal testing when possible.
In this context, the SCCNFP has
a specific working group on
alternatives to animal testing
which, in co-operation with
other Commission services such
as ECVAM (European Centre for
Validation of Alternative
Methods), evaluates these
methods.
SCCNFP opinions include
evaluations of experiments
using laboratory animals; such
tests are conducted in
accordance with all legal
provisions and preferably under
chemical law regulations. Only
in cases where no alternative
method is available will such
tests be evaluated and the
resulting data accepted, in
order to meet the fundamental
requirements of the protection
of consumer health.